Automated evaluation of pharmaceutically active ionic liquids' (eco)toxicity through the inhibition of human carboxylesterase and Vibrio fischeri

Journal of Hazardous Materials

Volumn 265, Issue , 2014, Pages 133-141

  Costa, Susana P F ^a   Justina, Vanessa D ^a   Bica, Katharina ^b   Vasiloiu, Maria ^b   Pinto, Paula C A G ^a   Saraiva, M Lúcia M F S ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Human toxicity; Pharmaceutically active ionic liquids; SIA; Vibrio fischeri

Indexed keywords

AUTOMATION; IONIC LIQUIDS;

AUTOMATED EVALUATION; HUMAN TOXICITY; INHIBITOR CONCENTRATION; PHARMACEUTICAL DRUGS; SEQUENTIAL INJECTION ANALYSIS; SIA; STRUCTURAL ELEMENTS; VIBRIO FISCHERI;

TOXICITY;

1 ETHYL 3 METHYLIMIZADOLIUM SALICYLATE; BENZALKONIUM; BENZETHONIUM BISTRIFLIMIDE; BENZETHONIUM CHLORIDE; BENZETHONIUM DOCUSATE; CARBOXYLESTERASE; CETYLPYRIDINIUM SALT; DOCUSATE SODIUM; IMIDAZOLE DERIVATIVE; IONIC LIQUID; SALICYLIC ACID DERIVATIVE; TRIHEXYLTETRADECYLPHOSPHONIUM DOCUSATE; TRIHEXYLTETRADECYLPHOSPHONIUM SALICYLATE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; AUTOMATION; BACTERIUM; BIOASSAY; CONCENTRATION (COMPOSITION); DRUG; DRUG DEVELOPMENT; ECOTOXICOLOGY; ENZYME ACTIVITY; HOMINID; INHIBITOR; TOXICITY TEST;

ALIIVIBRIO FISCHERI; ARTICLE; BIOASSAY; CONTROLLED STUDY; ECOTOXICITY; NONHUMAN; SEQUENTIAL INJECTION ANALYSIS; SUSTAINABLE DEVELOPMENT; SYNTHESIS;

APIS; VIBRIO FISCHERI;

(HEX)(3)(TDEC)PCL; (HEX)(3)(TDEC)PD; (HEX)(3)(TDEC)PSAL; (HEX)(3)(TDEC)PTF(2)N; 1-ETHYL-3-METHYL-IMIDAZOLIUM CHLORIDE; 1-ETHYL-3-METHYL-IMIDAZOLIUM SALICYLATE; 4-METHYLUMBELIFERYL ACETATE; ACTIVE PHARMACEUTICAL INGREDIENTS; APIS; BACL; BASAL; BECL; BED; BENZALKONIUM CHLORIDE; BENZALKONIUM SALICYLATE; BENZETHONIUM BISTRIFLIMIDE; BENZETHONIUM CHLORIDE; BENZETHONIUM DOCUSATE; BENZETHONIUM SALICYLATE; BESAL; BETF(2)N; CETPYCL; CETPYSAL; CETYLPYRIDINIUM CHLORIDE; CETYLPYRIDINIUM SALICYLATE; DIMETHYLSULFOXIDE; DMSO; EMIMCL; EMIMSAL; HCE; HUMAN CARBOXYLESTERASE; HUMAN TOXICITY; IL-APIS; ILS; IONIC LIQUIDS; MUA; NAD; NASAL; PHARMACEUTICAL ACTIVE IONIC LIQUIDS; PHARMACEUTICALLY ACTIVE IONIC LIQUIDS; SEQUENTIAL INJECTION ANALYSIS; SIA; SODIUM DOCUSATE; SODIUM SALICYLATE; TRIHEXYLTETRADECYLPHOSPHONIUM BISTRIFLIMIDE; TRIHEXYLTETRADECYLPHOSPHONIUM CHLORIDE; TRIHEXYLTETRADECYLPHOSPHONIUM DOCUSATE; TRIHEXYLTETRADECYLPHOSPHONIUM SALICYLATE; VIBRIO FISCHERI;

ALIIVIBRIO FISCHERI; BIOLOGICAL ASSAY; CARBOXYLESTERASE; HUMANS; IONIC LIQUIDS; LUMINESCENT MEASUREMENTS;

EID: 84890587379     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2013.11.052     Document Type: Article

References (49)

1. Moniruzzaman M., Nakashima K., Kamiya N., Goto M. Recent advances of enzymatic reactions in ionic liquids. Biochem. Eng. J. 2010, 48:295-314.
2. Wasserscheid P., Welton T. Ionic Liquids in Synthesis 2008, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. second ed.
3. Hough W.L., Smiglak M., Rodriguez H., Swatloski R.P., Spear S.K., Daly D.T., Pernak J., Grisel J.E., Carliss R.D., Soutullo M.D., Davis J.H., Rogers R.D. The third evolution of ionic liquids: active pharmaceutical ingredients. New J. Chem. 2007, 31:1429-1436.
4. Deetlefs M., Seddon K.R., Shara M. Predicting physical properties of ionic liquids. Phys. Chem. Chem. Phys. 2006, 8:642-649.
5. Ferraz R., Branco L.C., Prudencio C., Noronha J.P., Petrovski Z. Ionic liquids as active pharmaceutical ingredients. ChemMedChem 2011, 6:975-985.
6. Cutter C.N., Dorsa W.J., Handie A., Rodriguez-Morales S., Zhou X., Breen P.J., Compadre C.M. Antimicrobial activity of cetylpiridinium chloride washes against pathogenic bacteria on beef surfaces. J. Food Prot. 2000, 63:593-600.
7. Wu T., Xie A.-G., Tan S.-Z., Cai X. Antimicrobial effects of quaternary phosphonium salt intercalated clay minerals on Escherichia coli and Staphylococci aureaus. Colloid Surf. B: Biointerfaces 2011, 86:232-236.
8. Busetti A., Crawford D.E., Earle M.J., Gilea M.A., Gilmore B.F., Gorman S.P., Laverty G., Lowry A.F., McLaughlin M., Seddon K.R. Antimicrobial and antibiofilm activities of 1-alkylquinolinium bromide ionic liquids. Green Chem. 2010, 12:420-425.
9. Stoimenovski J., MacFarlane D.R., Bica K., Rogers R.D. Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper. Pharm. Res. 2010, 27:521-526.
10. Bica K., Rijksen C., Nieuwenhuyzen M., Rogers R.D. In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid. Phys. Chem. Chem. Phys. 2010, 12:2011-2017.
11. Malhotra S.V., Kumar V. A profile of the in vitro anti-tumor activity of imidazolium-based ionic liquids. Bioorg. Med. Chem. Lett. 2010, 20:581-585.
12. Maddali K., Kumar V., Marchand C., Pommier Y., Malhotra S.V. Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors. MedChemComm 2011, 2:143-150.
13. Pham T.P., Cho C.W., Yun Y.S. Environmental fate and toxicity of ionic liquids: a review. Water Res. 2010, 44:352-372.
14. Santos L.H., Araujo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45-95.
15. de la Torre F.R., Salibián A., Ferrari L. Enzyme activities as biomarkers of freshwater pollution: responses of fish branchial (Na+K)-ATPase and liver transaminases. Environ. Toxicol. 1999, 14:313-319.
16. Napierska D., Barsiene J., Mulkiewicz E., Podolska M., Rybakovas A. Biomarker responses in flounder Platichthys flesus from the Polish coastal area of the Baltic Sea and applications in biomonitoring. Ecotoxicology 2009, 18:846-859.
17. Torrecilla J.S., Garcia J., Rojo E., Rodriguez F. Estimation of toxicity of ionic liquids in Leukemia Rat Cell Line and Acetylcholinesterase enzyme by principal component analysis, neural networks and multiple lineal regressions. J. Hazard. Mater. 2009, 164:182-194.
18. Laizure S.C., Herring V., Hu Z.Y., Witbrodt K., Parker R.B. The role of human carboxylesterases in drug metabolism: have we overlooked their importance?. Pharmacotherapy 2013, 33:210-222.
19. Schwer H., Langmann T., Daig R., Becker A., Aslanidis C., Schmitz G. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun. 1997, 233:117-120.
20. Wheelock C.E., Phillips B.M., Anderson B.S., Miller J.L., Miller M.J., Hammock B.D. Applications of carboxylesterase activity in environmental monitoring and toxicity identification evaluations (TIEs). Rev. Environ. Contam. Toxicol. 2008, 195:117-178.
21. Cunha E., Pinto P.C.A.G., Carvalho J.P.S., Saraiva M.L.M. Automated carboxylesterase assay for the evaluation of ionic liquids' human toxicity. J. Hazard. Mater. 2013, 244:563-569.
22. Komaitis E., Vasiliou E., Kremmydas G., Georgakopoulos D.G., Georgiou C. Development of a fully automated flow injection analyzer implementing bioluminescent biosensors for water toxicity assessment. Sensors 2010, 10:7089-7098.
23. Tang J.Y.M., McCarty S., Glenn E., Neale P.A., Warne M.S.J., Escher B.I. Mixture effects of organic micropollutants present in water: towards the development of effect-based water quality trigger values for baseline toxicity. Water Res. 2013, 47:3300-3314.
24. Ventura S.P.M., Marques C.S., Rosatella A.A., Afonso C.A.M., Goncalves F., Coutinho J.A.P. Toxicity assessment of various ionic liquid families towards Vibrio fischeri marine bacteria. Ecotoxicol. Environ. Saf. 2012, 76:162-168.
25. Parvez S., Venkataraman C., Mukherji S. A review on advantages of implementing luminescence inhibition test (Vibrio fischeri) for acute toxicity prediction of chemicals. Environ. Int. 2006, 32:265-268.
26. Ruzicka J., Marshall G.D. Sequential injection - a new concept for chemical sensors, process analysis and laboratory assays. Anal. Chim. Acta 1990, 237:329-343.
27. Silvestre C.I.C., Pinto P.C.A.G., Segundo M.A., Saraiva M.L.M., Lima J.L.F.C. Enzyme based assays in a sequential injection format: a review. Anal. Chim. Acta 2011, 689:160-177.
28. Mesquita R.B.R., Rangel A.O.S.S. A review on sequential injection methods for water analysis. Anal. Chim. Acta 2009, 648:7-22.
29. Pinto P.C.A.G., Saraiva M.L.M., Lima J.L.F.C. Sequential injection analysis as a tool for implemention of enzymatic assays in ionic liquids. Talanta 2008, 77:479-483.
30. Pinto P.C.A.G., Costa S.P.F., Lima J.L.F.C., Saraiva M.L.M. Automated high-throughput Vibrio fischeri assay for (eco)toxicity screening: application to ionic liquids. Ecotoxicol. Environ. Saf. 2012, 80:97-102.
31. Wadkins R.M., Hyatt J.L., Wei X., Yoon K.J., Wierdl M., Edwards C.C., Morton C.L., Obenauer J.C., Damodaran K., Beroza P., Danks M.K., Potter P.M. Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases. J. Med. Chem. 2005, 48:2906-2915.
32. Arning J., Stolte S., Boschen A., Stock F., Pitner W.R., Welz-Biermann U., Jastorff B., Ranke J. Qualitative and quantitative structure activity relationships for the inhibitory effects of cationic head groups, functionalised side chains and anions of ionic liquids on acetylcholinesterase. Green Chem. 2008, 10:47-58.
33. Ranke J., Muller A., Bottin-Weber U., Stock F., Stolte S., Arning J., Stormann R., Jastorff B. Lipophilicity parameters for ionic liquid cations and their correlation to in vitro cytotoxicity. Ecotoxicol. Environ. Saf. 2007, 67:430-438.
34. Luis P., Garea A., Irabien A. Quantitative structure-activity relationships (QSARs) to estimate ionic liquids ecotoxicity EC50 (Vibrio fischeri). J. Mol. Liq. 2010, 152:28-33.
35. Luis P., Ortiz I., Aldaco R., Irabien A. A novel group contribution method in the development of a QSAR for predicting the toxicity (Vibrio fischeri EC50) of ionic liquids. Ecotoxicol. Environ. Saf. 2007, 67:423-429.
36. Pretti C., Chiappe C., Baldetti I., Brunini S., Monni G., Intorre L. Acute toxicity of ionic liquids for three freshwater organisms: Pseudokirchneriella subcapitata, Daphnia magna and Danio rerio. Ecotoxicol. Environ. Saf. 2009, 72:1170-1176.
37. Ivankovic T., Hrenovic J. Surfactants in the environment. Arh. Hig. Rada. Toksikol. 2010, 61:95-110.
38. Viboud S., Papaïconomou N., Cortesi A., Chatel G., Draye M., Fontvieille D. Correlating the structure and composition of ionic liquids with their toxicity on Vibrio fischeri: a systematic study. J. Hazard. Mater. 2012, 215/216:40-48.
39. Hough W.L., Rogers R.D. Ionic liquids then and now: from solvents to materials to active pharmaceutical ingredients. Bull. Chem. Soc. Jpn. 2007, 80:2262-2269.
40. Frade R.F.M., Rosatella A.A., Marques C.S., Branco L.C., Kulkarni P.S., Mateus N.M.M., Afonso C.A.M., Duarte C.M.M. Toxicological evaluation on human colon carcinoma cell line (CaCo-2) of ionic liquids based on imidazolium, guanidinium, ammonium, phosphonium, pyridinium and pyrrolidinium cations. Green Chem. 2009, 11:1660-1665.
41. Bakshi M.S., Singh J., Singh K., Kaur G. Mixed micelles of cationic gemini with tetraalkyl ammonium and phosphonium surfactants: the head group and hydrophobic tail contributions. Colloid Surf. A: Physicochem. Eng. Aspects 2004, 234:77-84.
42. Mukherjee I., Mukherjee S., Naskar B., Ghosh S., Moulik S.P. Amphiphilic behavior of two phosphonium based ionic liquids. J. Colloid Interface Sci. 2013, 395:135-144.
43. Ranke J., Molter K., Stock F., Bottin-Weber U., Poczobutt J., Hoffmann J., Ondruschka B., Filser J., Jastorff B. Biological effects of imidazolium ionic liquids with varying chain lengths in acute Vibrio fischeri and WST-1 cell viability assays. Ecotoxicol. Environ. Saf. 2004, 58:396-404.
44. Crow J.A., Bittles V., Herring K.L., Borazjani A., Potter P.M., Ross M.K. Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon. Toxicol. Appl. Pharmacol. 2012, 258:145-150.
45. Fleming C.D., Bencharit S., Edwards C.C., Hyatt J.L., Tsurkan L., Bai F., Fraga C., Morton C.L., Howard-Williams E.L., Potter P.M., Redinbo M.R. Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil. J. Mol. Biol. 2005, 352:165-177.
46. Schiel M.A., Green S.I., Davis W.I., Sanghani P.C., Bosron W.F., Sanghani S.P. Expression and characterization of a human carboxylesterase 2 splice variant. J. Pharmacol. Exp. Ther. 2007, 323:94-101.
47. Satoh T., Hosokawa M. Structure, function and regulation of carboxylesterases. Chem. Biol. Interact. 2006, 162:195-211.
48. Escher B.I., Schwarzenbach R.P. Mechanistic studies on baseline toxicity and uncoupling of organic compounds as a basis for modeling effective membrane concentrations in aquatic organisms. Aquat. Sci. 2002, 64:20-35.
49. Stolte S., Matzke M., Arning J., Boschen A., Pitner W.R., Welz-Biermann U., Jastorff B., Ranke J. Effects of different head groups and functionalised side chains on the aquatic toxicity of ionic liquids. Green Chem. 2007, 9:1170-1179.